±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 645  |  »Ø¸´: 1
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

ÒøÉþ

ľ³æ (ÖøÃûдÊÖ)

Ö²Îï²ËÄñ

[ÇóÖú] ÇóÖú£¬ÓйØÖ×ÁöÀàÎÊÌâµÄµ¥´Ê¾ä×Ó·­Òë

1¡¢patients who developed resistance to anti-EGFR antibodies and recapitulation of treatment regime in patient-derived xenografts models

2¡¢patient-derived xenografts     proffered paper    Synthetic lethality

3¡¢in the evolution of pharmacoepigenetics

4¡¢Outside promoter methylation, the genetic defects in epigenetic genes confer resistance to epigenetic and classical drugs.

5¡¢ a dynamic DNA methylation£¨¼×»ù»¯£© of promoter£¨Æô¶¯×Ó£© and genes bodies is associated to the epithelial to mesenchymal transition in cancer

» ²ÂÄãϲ»¶

°®ºÃÖ²Îµ«ÊÇÊÇÒ»Ö»²ËÄñ£¡
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ssssllllnnnn

ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)

Translator and Proofreader


¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
ÒøÉþ: ½ð±Ò+20, ·­ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, ллÄãµÄ½âÊÍ£¬°ïÖúÌ«´óÁË 2015-05-06 22:34:33
²»ÊÇÑϸñµÄ·­Ò룬ÊÇ·­Òë¼Ó½âÊÍ¡£ÕâÑù¿ÉÄܶÔÄã°ïÖú¸ü´ó£º
1¡¢²¡È˶Կ¹EGFR£¨±íƤÉú³¤Òò×ÓÊÜÌ壩³öÏÖÄÍÒ©£¬µ«Ô´Óڸò¡È˵ÄÒìÖÖÒÆÖ²ÎïÄ£ÐÍ»á¶Ô£¨Í¬ÑùµÄ£©ÖÎÁÆ·½°¸Ãô¸Ð¡£
2¡¢patient-derived xenografts£º¾ÍÊÇÔ´ÓÚ²¡È˵ÄÒìÖÖÒÆÖ²ÎÔÚÂãÊóÉϽÓÖÖ²¡ÈËÖ×Áöϸ°û³¤³öÖ×Áö£¬ÕâÖÖСÊó½ÐºÉÁöСÊ󣩣»proffered paper£ºÕâÓëÖ×ÁöÓйØÏµ£¿Õâͨ³£ÊDzμӻáÒé¡°Ìá½»µÄÂÛÎÄ¡±µÈ£¬Äã½áºÏ¿´Ò»Ï£» Synthetic lethality£ºÖ±½Ó·­ÒëÊǺϳÉÖÂËÀ£¬Êµ¼ÊÒâÒåÊÇÖ¸³öÏÖÁ½¸ö»ò¶à¸öÍ»±äÒýÆðËÀÍö¡£
3¡¢Ò©Àí±í¹ÛÒÅ´«Ñ§µÄÑݱä
4¡¢Æô¶¯×ÓÖ®Íâ£¨ÇøÓò£©µÄ¼×»ù»¯£¬»ùÒòµÄ±í¹ÛÒÅ´«È±Ïݶ¼¿ÉÒýÆð£¨¸³Ó裩¶Ô±í¹ÛÒÅ´«Ñ§Ò©ÎïºÍ´«Í³Ò©ÎïµÄÄÍÊÜ¡£
5¡¢Æô¶¯×Ó¼°±àÂë»ùÒòµÄ¶¯Ì¬¼×»ù»¯ÓëÖ×ÁöÖÐÉÏÆ¤Ïò¼äÖÊÒÆÐÐת±äÏà¹Ø¡£

Èç¹û¶Ôepigenetics£¨±í¹ÛÒÅ´«Ñ§£©²»Ã÷°×£¬¿ÉÒÔ×Ô¼ºÔÙ²éһϣ¬ÎÒ²»¿ÉÄÜÒ»ÏÂ×Óʲô¶¼¸æËßÄã¡£¼òµ¥Ëµ»ùÒòµÄ¼×»ù»¯¡¢ÒÒõ£»¯µÈµÈ¶¼ÊÇÕâ¸öÄÚÈÝ¡£
2Â¥2015-05-06 22:13:56
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ÒøÉþ µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 329Çóµ÷¼Á£¬Ò»Ö¾Ô¸Î÷±±¹¤Òµ´óѧ£¬²ÄÁϹ¤³Ì£¨085601£© +8 СС»úÁ鳿 2026-03-29 14/700 2026-04-03 19:38 by lijunpoly
[¿¼ÑÐ] Çóµ÷¼Á +8 akdhjs 2026-04-03 8/400 2026-04-03 18:17 by ´÷άING
[¿¼ÑÐ] 334Çóµ÷¼Á +9 Trying] 2026-03-31 9/450 2026-04-03 15:18 by ×ÁçíØ¼
[¿¼ÑÐ] 326·ÖÇóµ÷¼Á +3 ÓÚÊǺõÄØ 2026-04-01 5/250 2026-04-03 14:23 by ÓÚÊǺõÄØ
[¿¼ÑÐ] ³õÊԳɼ¨337ÕÒµ÷¼Á +3 ??? ?. ? 2026-04-03 3/150 2026-04-03 11:43 by ÍÁľ˶ʿÕÐÉú
[¿¼ÑÐ] 306·Ö²ÄÁÏÓ뻯¹¤Çóµ÷¼Á +4 Àè°ÉÀ²À²ÄãºÜÓÐà 2026-04-03 4/200 2026-04-03 11:24 by wangjy2002
[¿¼ÑÐ] µ÷¼Á +7 ìíáº. 2026-04-02 7/350 2026-04-03 09:11 by »¨ß»¹Ç·600
[¿¼ÑÐ] 260Çóµ÷¼Á +3 ÖìÜÆÁÕ 2026-04-02 3/150 2026-04-03 08:44 by yulian1987
[¿¼ÑÐ] 330·ÖÇóµ÷¼Á +15 qzenlc 2026-03-29 15/750 2026-04-02 21:41 by °ÙÁéͯ888
[¿¼ÑÐ] ÍÁľ304Çóµ÷¼Á +4 ÍÃͻͻͻ£¬ 2026-04-02 5/250 2026-04-02 21:16 by ÍÃͻͻͻ£¬
[¿¼ÑÐ] 283Çóµ÷¼Á +3 jiouuu 2026-04-02 4/200 2026-04-02 14:08 by ßÕßÕßÕßÉßÉßÉ
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©¿Æ¼¼´óѧ²ÄÁÏѧ˶328·ÖÇóµ÷¼Á +6 1¶Îʱ¼ä 2026-03-31 7/350 2026-04-02 13:57 by 3041
[¿¼ÑÐ] ÕÒµ÷¼Á +6 ³þÇÇÇÇ 2026-04-01 6/300 2026-04-02 12:06 by xiaoranmu
[¿¼ÑÐ] 261ÇóBÇøµ÷¼Á +5 Ã÷×С¤ 2026-04-01 7/350 2026-04-02 11:17 by ×Þξξ
[¿¼ÑÐ] 324Çóµ÷¼Á +5 ÏëÉÏѧÇóµ÷ 2026-04-01 6/300 2026-04-02 10:16 by sanrepian
[¿¼ÑÐ] 291Çóµ÷¼Á +20 Y-cap 2026-03-29 25/1250 2026-04-01 23:49 by ÐÀϲ777
[¿¼ÑÐ] 332Çóµ÷¼Á +8 Lyy930824@ 2026-03-29 8/400 2026-04-01 18:40 by ǧ¾û³ÎÓñÓî°¡
[¿¼ÑÐ] ÎïÀíѧµ÷¼Á +4 СÑò36 2026-03-30 4/200 2026-03-31 16:16 by lishahe
[¿¼ÑÐ] 353Çóµ÷¼Á +3 ½­ÉÏ·ã_26 2026-03-28 3/150 2026-03-31 15:53 by jp9609
[¿¼ÑÐ] Ò»Ö¾Ô¸ÄϾ©º½¿Õº½Ìì´óѧ²ÄÁÏѧ˶Çóµ÷¼Á +3 @taotao 2026-03-28 3/150 2026-03-28 10:26 by JourneyLucky
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û